Tesla
TSLA
ASML Holding
ASML
Alibaba
BABA
Apple
AAPL
Disney
DIS
US Stock MarketDetailed Quotes
ANTX AN2 Therapeutics
- 1.340
- -0.010-0.74%
Close Dec 17 16:00 ET
40.04MMarket Cap-0.67P/E (TTM)
1.370High1.320Low151.96KVolume1.340Open1.350Pre Close203.30KTurnover1.05%Turnover RatioLossP/E (Static)29.88MShares22.22052wk High0.46P/B19.39MFloat Cap0.87052wk Low--Dividend TTM14.47MShs Float23.580Historical High--Div YieldTTM3.70%Amplitude0.870Historical Low1.337Avg Price1Lot Size
AN2 Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -1.75%-12.01M | -12.16%-14.38M | -51.72%-17.59M | -59.25%-53.29M | -123.46%-17.07M | -24.38%-11.8M | -33.65%-12.82M | -72.00%-11.6M | -63.36%-33.46M | 15.07%-7.64M |
| Net income from continuing operations | 23.70%-12.75M | 8.66%-14.44M | -8.44%-16.62M | -58.05%-64.73M | -42.70%-16.9M | -47.34%-16.71M | -56.17%-15.8M | -100.17%-15.32M | -90.11%-40.96M | -56.95%-11.84M |
| Other non cash items | ---- | ---- | ---- | -31.17%53K | --0 | -35.00%13K | 10.53%21K | 5.56%19K | --77K | --20K |
| Change In working capital | -112.76%-431K | -190.05%-1.33M | -209.40%-2.27M | 56.91%5.83M | -135.50%-1.1M | 297.88%3.38M | 322.78%1.48M | 366.29%2.08M | 11,518.75%3.72M | 262.13%3.09M |
| -Change in prepaid assets | -1,633.33%-322K | 31.93%-795K | 49.46%1.11M | 38.86%-1.03M | -287.05%-621K | -96.69%21K | 43.79%-1.17M | 231.10%742K | -20.98%-1.68M | 131.92%332K |
| -Change in payables and accrued expense | -134.46%-826K | -129.03%-774K | -324.33%-3.03M | 14.14%6.25M | -105.67%-168K | 1,617.09%2.4M | 152.46%2.67M | -16.02%1.35M | 489.13%5.47M | 343.23%2.97M |
| -Change in other current liabilities | -25.31%717K | 1,238.10%239K | -1,721.05%-346K | 896.10%613K | -1,435.00%-307K | 4,900.00%960K | -10.53%-21K | -5.56%-19K | ---77K | ---20K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -1.75%-12.01M | -12.16%-14.38M | -51.72%-17.59M | -59.25%-53.29M | -123.46%-17.07M | -24.38%-11.8M | -33.65%-12.82M | -72.00%-11.6M | -63.36%-33.46M | 15.07%-7.64M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 129.97%18.72M | 108.96%16.46M | 141.48%26.29M | -98.79%-43.28M | -93.06%420K | -2,595.81%-62.46M | 119.95%7.88M | -22.11%10.89M | 56.48%-21.77M | -3.06%6.06M |
| Net investment purchase and sale | 129.97%18.72M | 108.96%16.46M | 141.48%26.29M | -98.79%-43.28M | -93.06%420K | -2,595.81%-62.46M | 119.95%7.88M | -22.11%10.89M | 56.48%-21.77M | -3.06%6.06M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 129.97%18.72M | 108.96%16.46M | 141.48%26.29M | -98.79%-43.28M | -93.06%420K | -2,595.81%-62.46M | 119.95%7.88M | -22.11%10.89M | 56.48%-21.77M | -3.06%6.06M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -99.97%23K | 0 | 75.38%349K | 20.81%84.99M | -321K | 660,760.00%66.07M | 165.39%19.05M | -99.69%199K | -10.42%70.36M | 0 |
| Net common stock issuance | --0 | ---- | ---- | 20.13%84.53M | ---321K | 658,100.00%65.8M | ---- | ---- | --70.37M | --0 |
| Proceeds from stock option exercised by employees | -91.35%23K | --0 | 75.38%349K | 4,327.27%465K | --0 | --266K | --0 | 1,909.09%199K | -200.00%-11K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -99.97%23K | --0 | 75.38%349K | 20.81%84.99M | ---321K | 660,760.00%66.07M | 165.39%19.05M | -99.69%199K | -10.42%70.36M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -34.41%26.77M | -7.55%24.69M | -42.51%15.65M | 125.01%27.22M | 13.24%32.62M | 0.48%40.81M | -67.63%26.71M | 125.01%27.22M | 197.22%12.1M | 82.14%28.8M |
| Current changes in cash | 182.17%6.74M | -85.28%2.08M | 1,873.73%9.05M | -176.52%-11.57M | -971.95%-16.97M | 30.62%-8.2M | 133.66%14.1M | -100.72%-510K | 88.39%15.12M | 57.40%-1.58M |
| End cash Position | 2.72%33.5M | -34.41%26.77M | -7.55%24.69M | -42.51%15.65M | -42.51%15.65M | 13.24%32.62M | 0.48%40.81M | -67.63%26.71M | 125.01%27.22M | 125.01%27.22M |
| Free cash flow | -1.75%-12.01M | -12.16%-14.38M | -51.72%-17.59M | -59.25%-53.29M | -123.46%-17.07M | -24.38%-11.8M | -33.65%-12.82M | -72.00%-11.6M | -63.36%-33.46M | 15.07%-7.64M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.